Interestingly, the study of Frankel et al.52 showed that Barnesiellaceae are more abundant in patients who do not develop adverse colitis upon receiving CTLA-4 check-point blockage cancer therapy, suggesting that the presence of this family correlates with a pronounced immunoregulatory phenotype of immune cells in these patients. This evidence concerns the gene CTLA4 and colitis.